Vita Life Sciences Limited (VLS.AX)
- Previous Close
1.8000 - Open
1.8000 - Bid 1.8000 x --
- Ask 1.8800 x --
- Day's Range
1.8000 - 1.8000 - 52 Week Range
1.6200 - 2.4000 - Volume
22,369 - Avg. Volume
34,345 - Market Cap (intraday)
99.363M - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
11.25 - EPS (TTM)
0.1600 - Earnings Date Feb 24, 2025
- Forward Dividend & Yield 0.10 (5.56%)
- Ex-Dividend Date Mar 21, 2025
- 1y Target Est
--
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.
vitalifesciences.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: VLS.AX
View MorePerformance Overview: VLS.AX
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VLS.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VLS.AX
View MoreValuation Measures
Market Cap
101.81M
Enterprise Value
73.73M
Trailing P/E
11.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.25
Price/Book (mrq)
1.90
Enterprise Value/Revenue
0.93
Enterprise Value/EBITDA
5.48
Financial Highlights
Profitability and Income Statement
Profit Margin
11.05%
Return on Assets (ttm)
11.06%
Return on Equity (ttm)
18.36%
Revenue (ttm)
79.5M
Net Income Avi to Common (ttm)
8.78M
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
28.6M
Total Debt/Equity (mrq)
0.99%
Levered Free Cash Flow (ttm)
4.43M